Aldara is First and Only Immune Response Modifier Indicated for the Treatment of Actinic Keratosis, Superficial Basal Cell Carcinoma and External Genital and Perianal Warts
3M announced today that Aldara Cream is a featured topic in multiple presentations by leading researchers at the American Academy of Dermatology's (AAD) ACADEMY 06 meeting in San Diego, July 26-30. Aldara Cream is the first and only immune response modifier indicated for the treatment of precancerous actinic keratosis, superficial basal cell carcinoma and external genital and perianal warts. The prescription therapy works by stimulating the skin's immune response to clear diseased or damaged cells.
Aldara posters can be viewed in the Ballroom 6 Lobby at the San Diego Convention Center on:
- Thursday, July 27 (7 a.m. - 7 p.m.)
- Friday, July 28 (7 a.m. - 7 p.m.)
- Saturday, July 29 (7 a.m. - 5:30 p.m.)
Aldara Cream Presentations
- Treating actinic keratosis on the head with imiquimod 5% cream applied once daily, 3 days per week in 1 or 2 courses of treatment
A. Alomar, MD. Poster 400.
- Treatment of actinic keratosis on the head with imiquimod 5% cream for 1 or 2 4-week courses of treatment and long-term clinical outcomes
Joseph Jorizzo, MD. Poster 403.
- 3-year recurrence rates of superficial basal cell carcinomas treated with imiquimod 7x/week for 6 weeks
K. Gebauer, MBBS. Poster 1901.
- 3-year recurrence rates of superficial basal cell carcinomas after treatment with imiquimod 5x/week for 6 weeks
H. Gollnick, MD. Poster 1902.
- Long-term follow-up of patients treated with topical imiquimod cycle therapy for actinic keratosis of the scalp and squamous cell carcinoma in situ
J. Del Rosso, DO. Poster 1905.
In addition to the poster presentations noted above, Aldara Cream also will be discussed during a ticketed symposium about immunomodulatory therapy on Saturday, July 29, from 2 p.m. - 5 p.m. in Room 6C at the San Diego Convention Center.
(Aldara Cream is indicated for actinic keratosis, superficial basal cell carcinoma, and external genital and perianal warts. As with all scientific meetings, results of studies that include investigational uses of drugs may be presented.)
About Aldara Cream
Aldara Cream is a topical (skin-use only) prescription medicine and is the first and only immune response modifier (IRM) approved to treat three skin conditions: actinic keratosis, a precancerous skin condition, superficial basal cell carcinoma, a form of skin cancer and external genital and perianal warts, caused by the Human Papillomavirus, or HPV. Aldara stimulates the body's own defense mechanism to identify and clear diseased and damaged cells. When using Aldara Cream, the most common side effects involved skin reactions in the application area. These included redness, swelling, erosions, induration, weeping, scabbing/crusting, flaking/scaling, itching and burning. Exposure to sunlight (including sunlamps) should be avoided or minimized during use of Aldara Cream for actinic keratosis or superficial basal cell carcinoma because of concern for heightened sunburn susceptibility. Patients should be warned to use protective clothing (hat) when using Aldara Cream. For full prescribing information see www.Aldara.com.
About 3M Pharmaceuticals - Part of the 3M Health Care Family
3M Health Care is a leading provider of solutions for medical, oral care, pharmaceutical, and health information systems markets. 3M Pharmaceuticals, part of the 3M Health Care family, develops, manufactures and sells branded prescription drug products for dermatology, women's health, sexual health, cardiology and respiratory medicine. More information about Aldara Cream is available at www.aldara.com.
About 3M - A Global, Diversified Technology Company
3M's brands include Scotch, Post-it, Scotchgard, Thinsulate, Scotch-Brite, Filtrete, Command and Vikuiti. Serving customers in more than 200 countries around the world, the people of 3M use their expertise, technologies and global strength to lead in major markets including consumer and office; display and graphics; electronics and telecommunications; safety, security and protection services; health care; industrial and transportation.
Aldara, Scotch, Post-it, Scotchgard, Thinsulate, Scotch-Brite, Filtrete, Command and Vikuiti are trademarks of 3M.
3MDonna Balitz (on-site), 651-226-4618orEmily Faucette, 415-595-9407orGlenn Carter, 651-737-0687
